Hypoglycemic Agents: all 3,927 studies that test it
Page 30 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Metformin & Inflammation in Pre-diabetic ChildrenCompletedNCT01394887Phase 2/3
- Polycystic Ovary Syndrome Genetics and Treatment ResponseStatus unknownNCT01389778Not applicable
- The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced ObesityCompletedNCT01384279Not applicable
- A Comparison of Two Initial Dosing FormulasCompletedNCT01377155Not applicable
- Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mgStatus unknownNCT01367054Not applicable
- Therapeutic Monitoring of Metformin in Women With Polycystic Ovary SyndromeStatus unknownNCT01366391Phase 4
- Pharmacokinetic Study in Healthy VolunteersCompletedNCT01365117Phase 1
- Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive SubjectsStatus unknownNCT01364675Not applicable
- Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DMCompletedNCT01357603Phase 1
- Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 DiabetesCompletedNCT01357252Phase 3
- Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 DiabetesCompletedNCT01356381Phase 4
- Metformin in Women With Type 2 Diabetes in Pregnancy TrialCompletedNCT01353391Phase 3
- Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)WithdrawnNCT01352026Phase 2
- Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes MellitusCompletedNCT01349855Phase 1
- Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes SplicingCompletedNCT01349387Not applicable
- Glucose Control in Pre-Diabetic Renal Transplant PatientsCompletedNCT01346254Phase 2
- Metformin in Postmenopausal Women With Metabolic SyndromeStatus unknownNCT01342744Phase 4
- The Effect of Metformin on the Correlation Between Hyperinsulinemia and HypertensionCompletedNCT01342614Not applicable
- Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid CancerCompletedNCT01341886Not applicable
- Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and InsulinCompletedNCT01341717Phase 4
- Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 DiabetesStatus unknownNCT01339143Phase 4
- Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver DiseasesStatus unknownNCT01337440Phase 4
- Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination TreatmentCompletedNCT01336751Phase 3
- Metformin and Sitagliptin in Women With Previous Gestational DiabetesCompletedNCT01336322Phase 2
- Pharmacist Intervention for Glycemic Control in The CommunityCompletedNCT01335763Not applicable
- Gene Expression Profiles and Metformin Efficacy in Type 2 DiabetesStatus unknownNCT01334684Not applicable
- The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)CompletedNCT01331967Phase 4
- Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)CompletedNCT01329016Phase 1/2
- Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)CompletedNCT01324180Phase 1
- Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus ErythematosusCompletedNCT01322308Phase 4
- A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic PatientsCompletedNCT01316107Phase 3
- Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy SubjectsCompletedNCT01309854Phase 1
- Drug Interaction of Vildagliptin (LAF237) With Voglibose in Japanese Patients With Type 2 DiabetesCompletedNCT01309698Phase 4
- Immunosafety Study of Recombinant Human Insulins in Type 1 DiabeticsTerminatedNCT01308437Phase 3
- Glucose Control in Severely Burned PatientsCompletedNCT01307306Not applicable
- BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed StatesWithdrawnNCT01305551Phase 1
- Effects of Alogliptin on Pancreatic Beta Cell FunctionStatus unknownNCT01303055Not applicable
- Drug-drug Interaction Study With ASP1941 and GlimepirideCompletedNCT01302158Phase 1
- Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic PatientsStatus unknownNCT01300637Not applicable
- A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1CompletedNCT01296438Phase 1
- Diabetic Retinopathy Sulodexide StudyCompletedNCT01295775Phase 2
- A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy SubjectsCompletedNCT01292993Phase 1
- BAY73-4506 Probe Substrate StudyCompletedNCT01287598Phase 1
- Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With EpilepsyCompletedNCT01284530Phase 1/2
- Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)CompletedNCT01279512Phase 4
- Study TO Prevent Diabetes With Short-term Insulin Glargine OnlyStatus unknownNCT01276912Not applicable
- Investigatory Study of Metformin's Pharmacokinetics, Pharmacodynamics and Drug Drug Interactions Classifying the Group by MATE1 Genotype in Healthy VolunteersCompletedNCT01274130Not applicable
- Metformin in Obese Non-diabetic Pregnant WomenCompletedNCT01273584Phase 2/3
- A Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult VolunteersCompletedNCT01273571Phase 1
- Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM DiagnosisStatus unknownNCT01271517Phase 4
- High Dose Insulin Therapy to Improve Liver FunctionStatus unknownNCT01271140Not applicable
- JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic PatientsCompletedNCT01269996Phase 4
- Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 DiabetesCompletedNCT01269606Phase 1
- Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe HyperglycemiaCompletedNCT01267448Phase 4
- Effect of Metformin on Breast Cancer MetabolismCompletedNCT01266486Phase 2
- Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.CompletedNCT01262586Phase 3
- Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 DiabetesTerminatedNCT01260246Not applicable
- Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) PatientsCompletedNCT01258322Not applicable
- Sitagliptin in Cystic Fibrosis-Related DiabetesTerminatedNCT01257464Phase 2
- Safety and Efficacy of Galvus in Elderly Type 2 Diabetes PatientsCompletedNCT01257451Phase 3
- Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRDStatus unknownNCT01253928Phase 4
- Chronic Reduction of Fasting Glycaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 DiabetesCompletedNCT01249677Phase 4
- Metformin in Chronic Obstructive Pulmonary DiseaseCompletedNCT01247870Phase 4
- A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes MellitusStatus unknownNCT01245166Phase 3
- Hyperinsulinemic Therapy in SepsisStatus unknownNCT01244178Not applicable
- Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate CancerCompletedNCT01243385Phase 2
- Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese SubjectsCompletedNCT01242826Phase 1
- Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin ResistanceCompletedNCT01240252Phase 1
- Insulin Detemir in Obesity ManagementActive, not recruitingNCT01239550Not applicable
- Phase 4 Study in the Elderly Patients With T2DMCompletedNCT01238978Phase 4
- A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian VolunteersCompletedNCT01237522Phase 4
- Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes MellitusCompletedNCT01235819Phase 4
- A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes MellitusCompletedNCT01235039Phase 1/2
- Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a DayCompletedNCT01234597Phase 4
- Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus GlimepirideCompletedNCT01233622Phase 3
- Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF CyclesCompletedNCT01233206Phase 4
- Reducing Antipsychotic-Induced Weight Gain in Children With MetforminCompletedNCT01231074Phase 1
- The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co.CompletedNCT01228240Phase 4
- Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT01224366Phase 3
- Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.CompletedNCT01223131Phase 3
- Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 DiabetesCompletedNCT01219400Phase 4
- Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?CompletedNCT01215331Phase 3
- Management of Type 2 Diabetes After Gastric Bypass SurgeryTerminatedNCT01213563Not applicable
- Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)CompletedNCT01212913Phase 4
- Metformin Combined With Chemotherapy for Pancreatic CancerCompletedNCT01210911Phase 2
- Insulin-like Growth Factor (IGF-I) in Hemodialysis PatientsCompletedNCT01209403Phase 4
- Metformin in Patients With PCOS and Predictors of Poor Ovarian Response Ongoing In-vitro FertilizationTerminatedNCT01208740Phase 4
- Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes MellitusStatus unknownNCT01206647Phase 4
- Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic PatientsCompletedNCT01206153Phase 4
- Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial CancerCompletedNCT01205672Early Phase 1
- Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)CompletedNCT01205282Phase 2
- baSal BoluS Therapy in patIenTs With TypE 1 Diabetes MellitusCompletedNCT01204593Phase 4
- ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose CombinationCompletedNCT01204580Phase 4
- Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering DrugsCompletedNCT01203111Phase 4
- Apidra Children & Adolescents StudyCompletedNCT01202474Phase 4
- PK/PD Study of Intranasal Insulin in Type I DiabetesStatus unknownNCT01201278Phase 1
- Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)CompletedNCT01196546Phase 4
- Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus®CompletedNCT01195454Phase 1
- Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 DiabetesCompletedNCT01194882Phase 3
- Glycemic Holter Study (Continuous Glucose Monitoring) -CompletedNCT01193296Phase 4